Listing 1 - 6 of 6 |
Sort by
|
Choose an application
The book contains nine articles on the subject of diagnosis and treatment of macular edema due to different causes. It presents both reviews of current recommendations of macular edema treatment as well as original research on specific forms of that entity.
Medicine --- angiogenesis --- angiopoietin-1 --- central serous chorioretinopathy --- proangiogenic factors --- combined treatment --- subthreshold diode micropulse --- anti-VEGF treatment --- diabetic macular edema --- retinal vein occlusion --- Coats disease --- peripheral retinal telangiectasia --- laser photocoagulation --- hypotony maculopathy --- complications of antiglaucoma surgery --- bleb compressive sutures --- age-related macular degeneration --- AMD --- proteomics --- tear film --- tear film proteome --- protein clearance --- neovascularization --- neovascular AMD --- macular edema --- uveitis --- uveitic complications --- non-steroidal anti-inflammatory drugs --- steroids --- biologic treatment --- Irvine–Gass syndrome --- cystoid macular edema --- pseudophakic cystoid macular edema --- NSAIDs corticosteroids --- anti-VEGF --- intravitreal injections --- intravitreal agents --- best corrected visual acuity --- central retinal thickness --- adverse drug reactions --- intravitreal drug expenses
Choose an application
The book contains nine articles on the subject of diagnosis and treatment of macular edema due to different causes. It presents both reviews of current recommendations of macular edema treatment as well as original research on specific forms of that entity.
angiogenesis --- angiopoietin-1 --- central serous chorioretinopathy --- proangiogenic factors --- combined treatment --- subthreshold diode micropulse --- anti-VEGF treatment --- diabetic macular edema --- retinal vein occlusion --- Coats disease --- peripheral retinal telangiectasia --- laser photocoagulation --- hypotony maculopathy --- complications of antiglaucoma surgery --- bleb compressive sutures --- age-related macular degeneration --- AMD --- proteomics --- tear film --- tear film proteome --- protein clearance --- neovascularization --- neovascular AMD --- macular edema --- uveitis --- uveitic complications --- non-steroidal anti-inflammatory drugs --- steroids --- biologic treatment --- Irvine–Gass syndrome --- cystoid macular edema --- pseudophakic cystoid macular edema --- NSAIDs corticosteroids --- anti-VEGF --- intravitreal injections --- intravitreal agents --- best corrected visual acuity --- central retinal thickness --- adverse drug reactions --- intravitreal drug expenses
Choose an application
The book contains nine articles on the subject of diagnosis and treatment of macular edema due to different causes. It presents both reviews of current recommendations of macular edema treatment as well as original research on specific forms of that entity.
Medicine --- angiogenesis --- angiopoietin-1 --- central serous chorioretinopathy --- proangiogenic factors --- combined treatment --- subthreshold diode micropulse --- anti-VEGF treatment --- diabetic macular edema --- retinal vein occlusion --- Coats disease --- peripheral retinal telangiectasia --- laser photocoagulation --- hypotony maculopathy --- complications of antiglaucoma surgery --- bleb compressive sutures --- age-related macular degeneration --- AMD --- proteomics --- tear film --- tear film proteome --- protein clearance --- neovascularization --- neovascular AMD --- macular edema --- uveitis --- uveitic complications --- non-steroidal anti-inflammatory drugs --- steroids --- biologic treatment --- Irvine–Gass syndrome --- cystoid macular edema --- pseudophakic cystoid macular edema --- NSAIDs corticosteroids --- anti-VEGF --- intravitreal injections --- intravitreal agents --- best corrected visual acuity --- central retinal thickness --- adverse drug reactions --- intravitreal drug expenses --- angiogenesis --- angiopoietin-1 --- central serous chorioretinopathy --- proangiogenic factors --- combined treatment --- subthreshold diode micropulse --- anti-VEGF treatment --- diabetic macular edema --- retinal vein occlusion --- Coats disease --- peripheral retinal telangiectasia --- laser photocoagulation --- hypotony maculopathy --- complications of antiglaucoma surgery --- bleb compressive sutures --- age-related macular degeneration --- AMD --- proteomics --- tear film --- tear film proteome --- protein clearance --- neovascularization --- neovascular AMD --- macular edema --- uveitis --- uveitic complications --- non-steroidal anti-inflammatory drugs --- steroids --- biologic treatment --- Irvine–Gass syndrome --- cystoid macular edema --- pseudophakic cystoid macular edema --- NSAIDs corticosteroids --- anti-VEGF --- intravitreal injections --- intravitreal agents --- best corrected visual acuity --- central retinal thickness --- adverse drug reactions --- intravitreal drug expenses
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
Medicine --- aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby's fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti-vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen --- aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby's fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti-vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
Medicine --- aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby’s fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti–vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- n/a --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen --- Sorsby's fundus dystrophy
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby’s fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti–vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- n/a --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen --- Sorsby's fundus dystrophy
Listing 1 - 6 of 6 |
Sort by
|